PL2268292T3 - Sposób i kompozycje do leczenia raka - Google Patents

Sposób i kompozycje do leczenia raka

Info

Publication number
PL2268292T3
PL2268292T3 PL09723788T PL09723788T PL2268292T3 PL 2268292 T3 PL2268292 T3 PL 2268292T3 PL 09723788 T PL09723788 T PL 09723788T PL 09723788 T PL09723788 T PL 09723788T PL 2268292 T3 PL2268292 T3 PL 2268292T3
Authority
PL
Poland
Prior art keywords
cancer
compositions
treatment
Prior art date
Application number
PL09723788T
Other languages
English (en)
Inventor
Angelika Burger
Hans Hendriks
Bernardus Rademaker
Original Assignee
Kominox, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kominox, Inc. filed Critical Kominox, Inc.
Publication of PL2268292T3 publication Critical patent/PL2268292T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL09723788T 2008-03-27 2009-03-24 Sposób i kompozycje do leczenia raka PL2268292T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3998708P 2008-03-27 2008-03-27
US12/408,864 US20090246291A1 (en) 2008-03-27 2009-03-23 Method and compositions for treatment of cancer
EP09723788.7A EP2268292B1 (en) 2008-03-27 2009-03-24 Method and compositions for treatment of cancer
PCT/US2009/038104 WO2009120697A2 (en) 2008-03-27 2009-03-24 Method and compositions for treatment of cancer

Publications (1)

Publication Number Publication Date
PL2268292T3 true PL2268292T3 (pl) 2018-06-29

Family

ID=41114644

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09723788T PL2268292T3 (pl) 2008-03-27 2009-03-24 Sposób i kompozycje do leczenia raka

Country Status (20)

Country Link
US (2) US20090246291A1 (pl)
EP (1) EP2268292B1 (pl)
JP (2) JP5543956B2 (pl)
KR (1) KR101634138B1 (pl)
CN (2) CN102046187A (pl)
AU (1) AU2009228378B2 (pl)
BR (1) BRPI0909164A2 (pl)
CA (1) CA2719766C (pl)
CY (1) CY1120536T1 (pl)
DK (1) DK2268292T3 (pl)
ES (1) ES2656762T3 (pl)
HU (1) HUE036609T2 (pl)
LT (1) LT2268292T (pl)
MX (1) MX2010010621A (pl)
PL (1) PL2268292T3 (pl)
PT (1) PT2268292T (pl)
RU (1) RU2508116C2 (pl)
SI (1) SI2268292T1 (pl)
WO (1) WO2009120697A2 (pl)
ZA (1) ZA201006988B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1721615A1 (en) * 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US9447049B2 (en) 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
CA2772411C (en) * 2009-09-10 2017-08-22 Kominox, Inc. Cancer stem cell-targeted and drug resistant cancer therapy
US8795738B2 (en) * 2009-11-12 2014-08-05 Board Of Regents Of The University Of Texas System Use of arsenic for cancer therapy protection
US11084811B2 (en) 2010-03-01 2021-08-10 Oncternal Therapeutics, Inc. Compounds for treatment of cancer
WO2012012305A2 (en) * 2010-07-18 2012-01-26 Niiki Pharma Inc. Combination therapy using a ruthenium complex
JP5997156B2 (ja) * 2010-08-24 2016-09-28 ジーティーエックス・インコーポレイテッド 癌の治療のための化合物
US20120251628A1 (en) * 2011-03-30 2012-10-04 Young Joo Min Compositions and methods for treatment of cancer
CA2835631A1 (en) * 2011-05-12 2012-11-15 Board Of Regents, The University Of Texas System Use of arsenic for cancer therapy protection
US8834938B2 (en) 2011-05-18 2014-09-16 Board Of Regents Of The University Of Texas System Use of arsenic for cancer therapy protection
US20160184356A1 (en) * 2013-03-15 2016-06-30 Ke Jian Jim Liu Arsenic-based treatment of cancers and inflammatory disorders
KR101309844B1 (ko) 2013-03-15 2013-09-23 박상채 항암 활성 증진용 한약재 및 이의 제조방법
MX372671B (es) * 2013-07-19 2020-04-23 Onyx Therapeutics Inc Inhibidores de proteasoma de epoxicetona peptídica en combinacion con inhibidores de cinasa pim para el tratamiento de canceres.
CA3041357A1 (en) * 2016-12-01 2018-06-07 Eupharma Pty Ltd Diarsenic tetraoxide compositions and their use in the treatment of cancers
KR102868121B1 (ko) * 2018-03-22 2025-10-14 코미팜 인터내셔널 오스트레일리아 피티와이 엘티디 메타 아비산염을 포함하는 약학 조성물 및 제조 방법
CN116236505A (zh) * 2023-03-15 2023-06-09 上海市第四人民医院 三氧化二砷在制备肺神经内分泌癌治疗药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6875451B2 (en) * 1997-10-15 2005-04-05 Polarx Biopharmaceuticals Inc. Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds
TR200002243T2 (tr) * 1997-11-10 2000-12-21 Memorial Sloan-Kettering Cancer Center Arsenik trioksitin hazırlanması için işlem ve bunların kanser tedavisi için kullanımı.
KR20020083678A (ko) * 2001-04-28 2002-11-04 주식회사 한국미생물연구소 아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물
WO2003086424A1 (en) * 2002-04-10 2003-10-23 Korea Microbiological Laboratories, Ltd. Pharmaceutical composition comprising arsenite for the treatment of malignancy
EP1721615A1 (en) * 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis
US8097237B2 (en) * 2005-08-23 2012-01-17 Stc.Unm Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
US7867492B2 (en) * 2007-10-12 2011-01-11 The John Hopkins University Compounds for hedgehog pathway blockade in proliferative disorders, including hematopoietic malignancies

Also Published As

Publication number Publication date
SI2268292T1 (en) 2018-03-30
PT2268292T (pt) 2018-02-19
EP2268292B1 (en) 2017-12-27
AU2009228378A1 (en) 2009-10-01
CA2719766C (en) 2017-10-31
BRPI0909164A2 (pt) 2016-06-21
CN102046187A (zh) 2011-05-04
CA2719766A1 (en) 2009-10-01
WO2009120697A3 (en) 2010-02-18
ES2656762T3 (es) 2018-02-28
EP2268292A2 (en) 2011-01-05
WO2009120697A2 (en) 2009-10-01
ZA201006988B (en) 2012-05-30
EP2268292A4 (en) 2011-05-11
US20090246291A1 (en) 2009-10-01
WO2009120697A4 (en) 2010-04-15
CY1120536T1 (el) 2019-07-10
LT2268292T (lt) 2018-03-26
CN104997808A (zh) 2015-10-28
MX2010010621A (es) 2011-04-05
JP2014101387A (ja) 2014-06-05
JP2011515481A (ja) 2011-05-19
KR101634138B1 (ko) 2016-06-28
JP5543956B2 (ja) 2014-07-09
DK2268292T3 (en) 2018-03-12
HUE036609T2 (hu) 2018-07-30
KR20110009664A (ko) 2011-01-28
AU2009228378B2 (en) 2014-07-17
US20180055812A1 (en) 2018-03-01
RU2508116C2 (ru) 2014-02-27
RU2010143893A (ru) 2012-05-10

Similar Documents

Publication Publication Date Title
ZA201006988B (en) Method and compositions for treatment of cancer
IL267342A (en) Antibodies and preparations containing them for the treatment of cancer
IL218987A0 (en) Methods and compositions for treating cancer
PL2340042T3 (pl) Sposoby i kompozycje do leczenia raka
SG10201510152RA (en) Diagnostic methods and compositions for treatment of cancer
PL2200431T3 (pl) Nowe kompozycje i metody służące leczeniu raka
IL214255A0 (en) Methods and compositions for diagnosis and treatment of cancer
PL2350273T3 (pl) Kompozycje modyfikowanych ludzkich arginaz i sposoby leczenia nowotworu złośliwego
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
IL214349A0 (en) Compositions and methods for the treatment of cancer
IL199689A0 (en) Compounds and method for treatment of cancer
EP2176406A4 (en) COMPOSITIONS AND METHOD FOR CANCER TREATMENT
EP2225226A4 (en) COMPOUNDS AND METHOD FOR THE TREATMENT OF CANCER
EP2515652A4 (en) COMPOSITIONS AND METHODS FOR TREATING VITILIGO
IL196727A0 (en) Composition and method for treatment of tumors
GB0808326D0 (en) Compositions and methods for the treatment of fybromyalgia
LT3067054T (lt) Naujos kompozicijos ir būdai vėžiui gydyti